Boord, J.B., Maeda, K., Makowski, L., et al. Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler Thromb Vasc Biol 22 1686-1691 (2002).

Uysal, K.T., Scheja, L., Wiesbrock, S.M., et al. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141(9) 3388-3396 (2000).

Hotamisligil, G.S., Johnson, R.S., Distel, R.J., et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274 1377-1379 (1996).

Matarese, V., and Bernlohr, D.A. Purification of murine adipocyte lipid-binding protein. Characterization as a fatty acid- and retinoic acid-binding protein. J Biol Chem 263(28) 14544-14551 (1988).

Baxa, C.A., Sha, R.S., Buelt, M.K., et al. Human adipocyte lipid-binding protein: Purification of the protein and cloning of its complementary DNA. Biochemistry 28 8683-8690 (1989).

Melki, S.A., and Abumrad, N.A. Expression of the adipocyte fatty acid-binding protein in streptozotocin-diabetes: Effects of insulin deficiency and supplemenatation. J Lipid Res 34 1527-1534 (1993).

Distel, R.J., Robinson, G.S., and Spiegelman, B.M. Fatty acid regulation of gene expression. Transcriptional and post-transcriptional mechanisms. J Biol Chem 267(9) 5937-5941 (1992).

Perrella, M.A., Pellacani, A., Layne, M.D., et al. Absence of adipocyte fatty acid binding protein prevents the development of accelerated atherosclerosis in hypercholesterolemic mice. FASEB J 15 1774-1776 (2001).